Literature DB >> 17889486

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period.

Javier Pemán1, María Bosch, Emilia Cantón, Angel Viudes, Isidro Jarque, Micaela Gómez-García, José María García-Martínez, Miguel Gobernado.   

Abstract

Candida guilliermondii fungemia is usually described in adults with hematologic malignancies, but in children, only 2 episodes have been published. From 1995 to 2006, 7 episodes (5 in children) were detected in our hospital. Molecular typing excluded a common infection source. C. guilliermondii fungemia may occur in children with underlying conditions other than cancer.

Entities:  

Mesh：

Year:  2007        PMID： 17889486     DOI： 10.1016/j.diagmicrobio.2007.07.014

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  5 in total

1.  Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.

Authors:  Noura Al-Sweih; Suhail Ahmad; Leena Joseph; Seema Khan; Sandhya Vayalil; Rachel Chandy; Ziauddin Khan
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

2.  Candidemia due to Candida guilliermondii in an immuno-compromised infant: a case report and review of literature.

Authors:  Fatemeh Ahangarkani; Hamid Badali; Mohammad Sadegh Rezai; Tahereh Shokohi; Zahra Abtahian; Hassan Mahmoodi Nesheli; Hossein Karami; Emmanuel Roilides; Ahmad Tamaddoni
Journal:  Curr Med Mycol       Date:  2019-03

3.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

4.  Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948

5.  Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.

Authors:  Jing-Wei Cheng; Shu-Ying Yu; Meng Xiao; He Wang; Timothy Kudinha; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.